CARM CARISMA THERAP
CARISMA THERAP (CARM) Institutional Ownership
What the institutions did with CARM last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Only 3 managers reported a position this quarter, so the percentages above describe a very small sample.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| Union Bancaire Privee, UBP SA | 785 | 100.0% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| Merck & Co., Inc. | Sold Out | 1.5M | 0 | -1.5M |
| Ascentis Independent Advisors | Sold Out | 200 | 0 | -200 |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.